Factitious hypoglycemia, characterized by self-induced low blood glucose often through exogenous insulin or sulfonylurea use, typically presents diagnostic challenges and requires measurement of insulin, C-peptide, and sulfonylurea levels during hypoglycemia to differentiate it from endogenous hyperinsulinemic states.